The ‘war on terror’ weakened the first amendment. Now we desperately need it

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Financial Intelligence • Markets • World News • Independent Analysis
Published: 2026-09-11 • Permanent link

Fears of a measles outbreak have intensified after the Centers for Disease Control and Prevention (CDC) questioned two measles deaths in Pennsylvania. The CDC's decision has sparked concerns about the agency's ability to accurately track and report measles cases. The market has reacted negatively, with stocks in pharmaceutical companies and healthcare providers experiencing a decline. The Dow Jones Industrial Average has fallen by 2.5% since the announcement, with investors becoming increasingly cautious about the potential impact of the outbreak on the economy.

The implications of the CDC's decision are far-reaching, with investors and consumers alike taking notice. The outbreak could lead to increased demand for vaccines and treatments, which could drive up costs for pharmaceutical companies and healthcare providers. This, in turn, could lead to higher prices for consumers, who may struggle to afford the necessary medications. The potential economic impact is significant, with some experts predicting that the outbreak could lead to a decline in economic activity.

The CDC's handling of measles cases is not a new issue, however. In recent years, the agency has faced criticism for its handling of other infectious diseases, including the Ebola outbreak in West Africa. The CDC's reliance on data from state and local health departments has also been questioned, with some experts arguing that the agency's methods are flawed. Despite these criticisms, the CDC remains a trusted source of information on infectious diseases, and its decisions are closely watched by investors and consumers.

As the situation continues to unfold, investors will be watching for updates on the CDC's investigation into the two measles deaths. The agency's decision to question the deaths has sparked a heated debate about the role of the CDC in tracking and reporting infectious diseases. With the outbreak showing no signs of slowing, the CDC is likely to face increased scrutiny in the coming weeks and months. The outcome of the investigation will have significant implications for the economy and the healthcare industry as a whole.